Primary prevention of type 2 diabetes: lifestyle intervention works and saves money, but what should be done with smokers?

Editorial

Jaakko Tuomilehto. Ann Intern Med. 2005.

. 2005 Mar 1;142(5):381-3.

doi: 10.7326/0003-4819-142-5-200503010-00013.

No abstract available

Comment on

Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH; Multiple Risk Factor Intervention Trial Research Group. Davey Smith G, et al. Ann Intern Med. 2005 Mar 1;142(5):313-22. doi: 10.7326/0003-4819-142-5-200503010-00006. Ann Intern Med. 2005. PMID: 15738450 Clinical Trial.
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group. Herman WH, et al. Ann Intern Med. 2005 Mar 1;142(5):323-32. doi: 10.7326/0003-4819-142-5-200503010-00007. Ann Intern Med. 2005. PMID: 15738451 Free PMC article.